Outlook Therapeutics, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
financial.report
Occurred
2025-09-30
Reported
2025-12-19
Disclosure lag
80 days

Context

links are based on the recorded entity type
FieldRecorded value
EntityOutlook Therapeutics, Inc.
SourceSEC EDGAR
Source identifiercompanyfacts/CIK0001649989/2026-07-26
Event ID#27693

Recorded payload

JSON payload as stored after parsing
{
  "accession": "0001104659-25-123264",
  "canonical_covered": 12,
  "canonical_total": 12,
  "fiscal_period": "FY",
  "fiscal_year": 2025,
  "form": "10-K",
  "mapped_tag_share": 0.04282115869017632,
  "metrics": {
    "cash_and_equivalents": 8083085,
    "earnings_per_share_basic": -1.79,
    "earnings_per_share_diluted": -1.79,
    "gross_profit": 57205,
    "net_income": -62424863,
    "operating_cash_flow": -51829437,
    "operating_income": -67061666,
    "revenue": 1413535,
    "shareholders_equity": -32187661,
    "shares_outstanding": 53887233,
    "total_assets": 18584183,
    "total_liabilities": 50771844
  },
  "metrics_reported": 12,
  "period_end": "2025-09-30"
}

Source: SEC EDGAR · as of 2025-12-19T00:00:00Z

Outlook Therapeutics, Inc. — recorded event — Tapewire